Shutterstock On Tuesday, a drug inspired by ketamine and made by Johnson & Johnson became the first new depression drug in 35 years. Regulators approved the drug, a nasal spray called Spravato or esketamine. The approval comes on the heels of a favorable vote from experts last month who evaluated the drug’s safety and effectiveness. […]